Effects of the efficacy of the <i>Yi Shen Tiao Gan</i> formula on aromatase inhibitor associated musculoskeletal syndrome: a randomized controlled trial.

Front Pharmacol · 2025 · PMC12331576 · PMID 40786053

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

(544.38 ± 279.96), p = 0.68], while an increasing trend was observed in the control group.

also in 63,971 other papers

did not reach statistical significanceno p-value reported

After applying Bonferroni correction for multiple testing, these associations did not reach statistical significance.

also in 111,027 other papers

a decreasing trendno p-value reported

Intragroup comparisons showed no statistically significant differences ( p > 0.05) in bone metabolism levels after treatment in both groups, although β-CTX exhibited a decreasing trend in the treatment group [(567.42 ± 288.65) vs.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Effects of the efficacy of the &lt;i&gt;Yi Shen Tiao Gan&lt;/i&gt; formula on aromatase inhibitor associated musculoskeletal syndrome: a randomized controlled trial.

The sentences

Effects of the efficacy of the <i>Yi Shen Tiao Gan</i> formula on aromatase inhibitor associated musculoskeletal syndrome: a randomized controlled trial.